Perrigo (PRGO) Receivables (2013 - 2026)
Perrigo (PRGO) posted quarterly Receivables of $697.1 million for Q1 2026, up 12.65% year-over-year from $618.8 million in Q1 2025, and up 13.76% quarter-over-quarter from $612.8 million in Q4 2025.
Perrigo (PRGO) Receivables (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Receivables for 14 consecutive years, with $697.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables rose 12.65% year-over-year to $697.1 million; the TTM figure through Mar 2026 stood at $697.1 million (up 12.65% YoY), while the FY2025 annual figure was $612.8 million, up 12.58% from the prior year.
- Receivables climbed to $697.1 million in Q1 2026 per PRGO's latest filing, from $612.8 million in the prior quarter.
- Across five years, Receivables topped out at $785.9 million in Q3 2024 and bottomed at $612.8 million in Q4 2025.
- Historically, Receivables has averaged $705.3 million across 5 years, with a median of $707.7 million in 2022.
- Annual changes were most pronounced in 2025 — Receivables dropped 20.67% — and 2026, when it increased 12.65%.
- Perrigo's Receivables stood at $697.1 million in 2022, then rose by 6.1% to $739.6 million in 2023, then declined by 13.16% to $642.3 million in 2024, then decreased by 4.59% to $612.8 million in 2025, then gained by 13.76% to $697.1 million in 2026.
- Business Quant data shows PRGO's Receivables at $697.1 million in Q1 2026, $612.8 million in Q4 2025, and $644.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 1.08 Bn |
| 10 | Perrigo | 1.93 Bn | 1.53 Bn | 313.90 Mn | 709.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 709.90 Mn |
| Mar 28, 2026 | 697.10 Mn |
| Dec 31, 2025 | 612.80 Mn |
| Sep 27, 2025 | 644.40 Mn |
| Jun 28, 2025 | 678.20 Mn |
| Mar 29, 2025 | 618.80 Mn |
| Dec 31, 2024 | 642.30 Mn |
| Sep 28, 2024 | 785.90 Mn |
| Jun 29, 2024 | 726.00 Mn |
| Mar 30, 2024 | 780.00 Mn |
| Dec 31, 2023 | 739.60 Mn |
| Sep 30, 2023 | 737.80 Mn |
| Jul 1, 2023 | 754.10 Mn |
| Apr 1, 2023 | 738.70 Mn |
| Dec 31, 2022 | 697.10 Mn |
| Oct 1, 2022 | 707.70 Mn |
| Jul 2, 2022 | 750.30 Mn |
| Apr 2, 2022 | 679.30 Mn |
| Dec 31, 2021 | 652.90 Mn |
| Oct 2, 2021 | 769.60 Mn |